Accessibility Menu
 
Genenta Science S.p.A. logo

Genenta Science S.p.A.

(NASDAQ) GNTA

Current Price$0.71
Market Cap$12.74M
Since IPO (2021)-94%
5 YearN/A
1 Year-84%
1 Month-33%

Genenta Science S.p.A. Financials at a Glance

Market Cap

$12.74M

Revenue (TTM)

$0.00

Net Income (TTM)

$17.63M

EPS (TTM)

$-0.51

P/E Ratio

-1.30

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.71

Volume

400

Open

$0.70

Previous Close

$0.67

Daily Range

$0.70 - $0.74

52-Week Range

$0.59 - $10.00

GNTA News

No articles available.

GNTA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genenta Science S.p.A.

Industry

Biotechnology

Employees

13

CEO

Pierluigi Paracchi

Headquarters

Milan, MI 20132, IT

GNTA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-59%

Return on Capital

-43%

Return on Assets

-40%

Earnings Yield

-76.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.74M

Shares Outstanding

19.15M

Volume

400

Short Interest

0.00%

Avg. Volume

1.07M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$9.76M

EBITDA

$9.72M

Operating Cash Flow

$6.24M

Capital Expenditure

$4.47K

Free Cash Flow

$6.24M

Cash & ST Invst.

$12.66M

Total Debt

$14.60K

Genenta Science S.p.A. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$12.74M

N/A

Market Cap/Employee

$980.15K

N/A

Employees

13

N/A

Net Income

$3.83M

+42.9%

EBITDA

$3.37M

+0.6%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$10.11M

-54.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

-100.0%

Long Term Debt

$7.55M

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-40.37%

N/A

Return on Invested Capital

-43.23%

N/A

Free Cash Flow

$5.52K

+99.9%

Operating Cash Flow

$5.51K

+99.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
JUNSJupiter Neurosciences, Inc.
$0.38-4.31%
MDCXMedicus Pharma Ltd. Common Stock
$0.48-3.00%
SKYESkye Bioscience, Inc.
$0.62-2.77%
BRNSBarinthus Biotherapeutics plc
$0.57-5.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.48-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.64+0.01%
ANNAAleAnna
$8.39+0.54%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.79-0.01%

Questions About GNTA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.